Abstract MPWE43: Multi-trait Polygenic Risk Scores Improve Prediction of Heart Failure

S Shinhye Chung (University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States) B Brian Spitzer (Department of Medicine, Harvard Medical School;CardioVascular Institute (CVI), Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States) Q Qin Hui N Ngoc Quynh Nguyen (UTHealth School of Public Health, Houston, Texas, United States) T Taryn Alkis (The University of Texas Health Science Center at Houston, Houston, Texas, United States) C Chang Liu T Traci Bartz (University of Washington, Seattle, Washington, United States) E Eric Boerwinkle J Jennifer Brody (University of Washington, Seattle, WA, USA.) S Susan Cheng M Myriam Fornage M Michael Hall (University of Mississippi, Jackson, MS, USA.) B Bertha Hidalgo R Robert Kaplan D Donald Lloyd-Jones (Framingham Center for Population and Prevention Science, Framingham, MA) A Alanna Morrison (University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States) L Lawrence Phillips (Atlanta VA Medical Center, Decatur, Georgia, United States) B Bruce Psaty (University of Washington, Seattle, WA, USA.) L Laura Raffield M Maryam Rahafrooz (Brown University, Providence, Rhode Island, United States) C Carlos Rodriguez J Jerome Rotter (The Lundquist Institute, Torrance, California, United States) S Sanjiv Shah (Northwestern University Feinberg School of Medicine, Chicago) A Amil Shah (University of Texas Southwestern Medical Center, Dallas (A.S.).) K Kent Taylor (The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States) P Peter Wilson V Vanessa Xanthakis J Jacob Joseph Y Yan Sun T Tamar Sofer V Vasan Ramachandran (The University of Texas San Antonio School of Public Health, San Antonio, Texas, United States) B Bing Yu (College of Chemistry and Materials Science, Guangdong Provincial Key Laboratory of Supramolecular Coordination Chemistry)

Abstract

Background: While clinical risk factors (CRF) have been used to predict heart failure (HF), an end-stage syndrome with high morbidity and mortality, the role of polygenic risk score (PRS) in identifying HF risk prediction remains unclear. Method: Using genome-wide summary statistics, we constructed 52 PRSs, including 1 for HF, 43 for echocardiographic(echo) traits, and 8 for CRF. Associations with incident HF were evaluated in 31,650 trans-ancestry participants (55% non-White; mean follow-up 16 years) from seven cohorts from the Trans-Omics for Precision Medicine (TOPMed) program, randomly divided into training (80%) and testing (20%) sets. Cox regression models adjusted for demographic and CRF were used to relate PRSs and to incident HF. Least absolute shrinkage and selection operator (LASSO) feature selection was performed on HF-related PRSs to build a multi-trait PRS (mPRS) in the training set. Associations of mPRS with incident HF, HF with preserved and reduced left ventricular (LV) ejection fraction (HFpEF and HFrEF, respectively), were examined in the testing set, with predictive performance evaluated by the C-statistic. Replication was conducted in 510,074 participants from the Million Veteran Program (MVP). Results: In the training set (n=25,320, HF cases=3,380), 17 out of 52 PRSs were associated with incident HF, where PRSs for HF and LV ejection fraction showed the largest effects (Figure 1a, HR HF-PRS : 2.02,95% CI 1.97-2.08, HR LVEF-PRS :0.93, 95% CI 0.89-0.97, p-value <0.05). Nine HF-related PRSs (1 HF, 6 echo, 2 CRF) were selected by LASSO to construct a multi-trait PRS (mPRS). In the testing set (n=6330, HF cases=856), per SD increase of mPRS was associated with about twofold increase in the risk of incident HF and its subtypes (Figure 1b, HR HF : 1.81, 95% CI 1.68–1.96; HR HFpEF : 2.08, 95% CI 1.78-2.43; HR HFrEF :1.97, 95% CI 1.68-2.31), and the associations were stronger in White vs Non-white participants. The associations of mPRS with incident HF and its subtypes were replicated in MVP (Figure 1b, HR HF : 1.13, 95% CI 1.11–1.15; HR HFpEF : 1.09, 95% CI 1.07-1.11; HR HFrEF :1.17, 95% CI 1.15-1.19). Adding mPRS over CRF modestly improved HF and HFrEF prediction in the trans-ancestral and white group (Figure 1c, HF trans-ancestral : estimated C: 0.89, delta C=1%, all p-values<0.05). Conclusion: The component PRS and mPRS were associated with HF risk, and mPRS can improve the prediction of incident HF, highlighting the potential for identifying at-risk populations.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (32)

S

Shinhye Chung

University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States

B

Brian Spitzer

Department of Medicine, Harvard Medical School;CardioVascular Institute (CVI), Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Q

Qin Hui

N

Ngoc Quynh Nguyen

UTHealth School of Public Health, Houston, Texas, United States

T

Taryn Alkis

The University of Texas Health Science Center at Houston, Houston, Texas, United States

C

Chang Liu

T

Traci Bartz

University of Washington, Seattle, Washington, United States

E

Eric Boerwinkle

J

Jennifer Brody

University of Washington, Seattle, WA, USA.

S

Susan Cheng

M

Myriam Fornage

M

Michael Hall

University of Mississippi, Jackson, MS, USA.

B

Bertha Hidalgo

R

Robert Kaplan

D

Donald Lloyd-Jones

Framingham Center for Population and Prevention Science, Framingham, MA

A

Alanna Morrison

University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States

L

Lawrence Phillips

Atlanta VA Medical Center, Decatur, Georgia, United States

B

Bruce Psaty

University of Washington, Seattle, WA, USA.

L

Laura Raffield

M

Maryam Rahafrooz

Brown University, Providence, Rhode Island, United States

C

Carlos Rodriguez

J

Jerome Rotter

The Lundquist Institute, Torrance, California, United States

S

Sanjiv Shah

Northwestern University Feinberg School of Medicine, Chicago

A

Amil Shah

University of Texas Southwestern Medical Center, Dallas (A.S.).

K

Kent Taylor

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States

P

Peter Wilson

V

Vanessa Xanthakis

J

Jacob Joseph

Y

Yan Sun

T

Tamar Sofer

V

Vasan Ramachandran

The University of Texas San Antonio School of Public Health, San Antonio, Texas, United States

B

Bing Yu

College of Chemistry and Materials Science, Guangdong Provincial Key Laboratory of Supramolecular Coordination Chemistry